IFM Investors Pty Ltd trimmed its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 6.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 289,623 shares of the real estate investment trust's stock after selling 21,005 shares during the period. IFM Investors Pty Ltd's holdings in Healthpeak Properties were worth $5,856,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in DOC. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in Healthpeak Properties by 584.6% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 9,218,848 shares of the real estate investment trust's stock worth $186,405,000 after acquiring an additional 7,872,150 shares in the last quarter. Nuveen LLC bought a new position in Healthpeak Properties during the 1st quarter worth about $124,113,000. Resolution Capital Ltd bought a new position in Healthpeak Properties during the 4th quarter worth about $122,795,000. Invesco Ltd. grew its holdings in Healthpeak Properties by 20.7% during the 1st quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust's stock worth $467,311,000 after acquiring an additional 3,967,830 shares in the last quarter. Finally, Goldman Sachs Group Inc. grew its holdings in Healthpeak Properties by 57.8% during the 1st quarter. Goldman Sachs Group Inc. now owns 6,764,854 shares of the real estate investment trust's stock worth $136,785,000 after acquiring an additional 2,477,307 shares in the last quarter. 93.57% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
Several research analysts have issued reports on the stock. Wall Street Zen cut shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Monday, July 7th. Morgan Stanley lowered their price target on shares of Healthpeak Properties from $22.00 to $21.00 and set an "overweight" rating on the stock in a report on Friday, August 22nd. Deutsche Bank Aktiengesellschaft restated a "hold" rating and issued a $18.00 price target (down from $28.00) on shares of Healthpeak Properties in a report on Wednesday, August 20th. Wells Fargo & Company lowered their price target on shares of Healthpeak Properties from $20.00 to $18.00 and set an "equal weight" rating on the stock in a report on Wednesday, August 27th. Finally, Scotiabank cut shares of Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and lowered their price target for the company from $21.00 to $19.00 in a report on Tuesday, July 29th. Seven investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, Healthpeak Properties currently has a consensus rating of "Moderate Buy" and an average target price of $21.50.
Read Our Latest Stock Report on DOC
Healthpeak Properties Stock Up 1.2%
NYSE:DOC opened at $18.16 on Friday. The company's 50-day simple moving average is $17.76 and its 200-day simple moving average is $18.21. The stock has a market capitalization of $12.62 billion, a P/E ratio of 75.67, a P/E/G ratio of 2.31 and a beta of 1.07. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.28 and a current ratio of 1.28. Healthpeak Properties, Inc. has a fifty-two week low of $16.63 and a fifty-two week high of $23.26.
Healthpeak Properties (NYSE:DOC - Get Free Report) last released its earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 EPS for the quarter, hitting analysts' consensus estimates of $0.46. The company had revenue of $694.35 million during the quarter, compared to analysts' expectations of $697.14 million. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. Healthpeak Properties's revenue for the quarter was down .2% on a year-over-year basis. During the same period last year, the business earned $0.45 EPS. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. On average, equities analysts anticipate that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.
Healthpeak Properties Announces Dividend
The business also recently announced a monthly dividend, which was paid on Friday, August 29th. Investors of record on Monday, August 18th were paid a $0.1017 dividend. The ex-dividend date was Monday, August 18th. This represents a c) dividend on an annualized basis and a yield of 6.7%. Healthpeak Properties's dividend payout ratio (DPR) is 508.33%.
Insider Buying and Selling
In related news, CEO Scott M. Brinker bought 1,490 shares of the stock in a transaction that occurred on Monday, August 4th. The stock was bought at an average cost of $16.83 per share, for a total transaction of $25,076.70. Following the purchase, the chief executive officer directly owned 211,906 shares of the company's stock, valued at approximately $3,566,377.98. This trade represents a 0.71% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In the last ninety days, insiders have purchased 8,783 shares of company stock valued at $150,129. 0.23% of the stock is owned by company insiders.
About Healthpeak Properties
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.